首页|人脐带间充质干细胞对传统胎盘屏障模型屏障功能的影响及作用机制

人脐带间充质干细胞对传统胎盘屏障模型屏障功能的影响及作用机制

扫码查看
目的 通过构建体外胎盘屏障模型,研究人脐带间充质干细胞(hUC-MSC)对传统胎盘屏障模型功能的影响及其可能的分子机制.方法 将hUC-MSC、人脐静脉内皮细胞(HUVEC)和人滋养层细胞(HTR-8)共同培养于transwell中建立体外胎盘屏障模型,设置对照组(HUVEC+HTR-8)、forskolin 组(HUVEC+HTR-8+forskolin)、MSC 组(HUVEC+HTR-8+hUC-MSC)、MSC+forskolin组(HUVEC+HTR-8+hUC-MSC+forskolin),通过测量跨膜电阻值、荧光黄CH 的渗透性以及P-糖蛋白(P-gp)的活性,评估各组体外胎盘屏障模型的功能;利用实时荧光定量PCR(qRT-PCR)和Western blotting检测各组体外胎盘屏障模型中P-gp、紧密连接蛋白5(Claudin-5)、闭合小环蛋白-1(ZO-1)、ZO-2、血小板-内皮细胞黏附分子(CD31)的mRNA及蛋白表达水平;利用LC-MS/MS检测阿替洛尔、米诺地尔、美托洛尔3种渗透性工具药透过各组体外胎盘屏障模型的表观渗透系数(Papp),验证模型的功能完整性.结果 与对照组相比,forskolin、MSC、MSC+forskolin组的跨膜电阻值均显著增高(P<0.05、0.001)、P-gp外排功能均增强、荧光黄的Papp值均显著降低(P<0.05、0.01、0.001),且二者联用后作用效果尤为显著,表明该模型具备完整的屏障功能,且MSC+forskolin屏障功能最好;qRT-PCR和 Western blotting结果显示,与对照组相比,forskolin组P-gp、ZO-1、ZO-2、CD31 的表达显著增加(P<0.05、0.01、0.001),MSC组P-gp、Claudin5、ZO-1和CD31的表达也显著增加(P<0.05、0.01、0.001);联合应用后,各蛋白的mRNA及蛋白表达水平均更显著增加(P<0.01、0.001),表明hUC-MSC增强传统胎盘屏障功能;与对照组相比,各实验组的Papp值均降低,MSC+forskolin组3个工具药均差异显著,美托洛尔差异最显著.结论 hUC-MSC通过增强传统胎盘屏障模型中紧密连接蛋白和外排蛋白的表达,进一步增强了传统胎盘屏障模型的屏障功能.
Mechanisms of human umbilical cord mesenchymal stem cells enhancing barrier function of traditional placental barrier models
Objective To investigate the effect of human umbilical cord mesenchymal stem cells(hUC-MSC)on the function of the traditional placental barrier model and its molecular mechanism by constructing an in vitro placental barrier model.Methods hUC-MSC,human umbilical vein endothelial cells(HUVEC),and human trophoblast cells(HTR-8)were co-cultured in a transwell to establish an in vitro placental barrier model.The experiment included the following groups:HUVEC+HTR-8(control group),HUVEC+HTR-8+forskolin(forskolin group),HUVEC+HTR-8+MSC(MSC group),and HUVEC+HTR-8+MSC+forskolin(MSC+forskolin group).By measuring the transmembrane resistance,permeability of fluorescent dye CH,and the activity of P-gp,we assessed the functionality of the in vitro placental barrier models in each group.Using real-time fluorescence quantitative PCR(qRT-PCR)and Western blotting,we detected the mRNA and protein expression levels of the efflux protein P-gp,as well as the tight junction proteins Claudin5,ZO-1,ZO-2,and CD31 in the in vitro placental barrier model of each group.Additionally,LC-MS/MS was used to detect the apparent permeability coefficient(Papp)of atenolol,minoxidil,and metoprolol,three drugs with different permeabilities,to validate the integrity of the model.Results Compared with control group,the transmembrane resistance values of forskolin,MSC and MSC+forskolin groups were significantly increased(P<0.05,0.001),the effection function of P-gp was enhanced,and the Papp value of fluorescence yellow was significantly decreased(P<0.05,0.01,0.001).The combined effect of the two was particularly significant,indicating that the model had complete barrier function,and MSC+forskolin had the best barrier function.qRT-PCR and Western blotting results showed that compared with control group,the expressions of P-gp,ZO-1,ZO-2 and CD31 in forskolin group were significantly increased(P<0.05,0.01,0.001),and the expressions of P-GP,Claudin5,ZO-1 and CD31 in MSC group were also significantly increased(P<0.05,0.01,0.001),and after combined application,the mRNA and protein expression levels of each protein were significantly increased(P<0.01,0.001),indicating that hUC-MSC enhanced the traditional placental barrier function.Compared with control group,Papp values of all experimental groups were decreased,and there were significant differences among the three instrumental drugs in MSC+forskolin group,the most significant difference was metoprolol.Conclusion This study revealed the molecular mechanisms by which MSC enhance the expression of tight junction proteins and efflux proteins in the traditional placental barrier model,thereby enhancing the barrier function of the traditional placental barrier model.

human umbilical cord mesenchymal stem cellshuman umbilical vein endothelial cellshuman trophoblast cellsplacental barrierP-gp

韩巧巧、王泽、郭宇竹、孙英辉、赵天宇、慈小燕、崔涛、傅鹏、伊秀林、闫凤英

展开 >

安徽医科大学药学院,安徽合肥 230032

天津药物研究院有限公司,药物成药性评价与系统转化全国重点实验室,天津 300301

澳门科技大学药学院,澳门 999078

天津市细胞技术创新中心,天津和创生物技术有限公司,天津 300301

中国医学科学院药物代谢新技术创新单元,北京 100730

展开 >

人脐带间充质干细胞 人脐静脉内皮细胞 人滋养层细胞 胎盘屏障 P-糖蛋白

中国医科院医学与健康科技创新工程项目天津市"项目+团队"重点培养专项(创新类)天津市科技计划药物成药性评价与系统转化全国重点实验室项目

2019-I2M-5-020XC20203023ZGCXQY00050712023001

2024

药物评价研究
天津药物研究院 中国药学会

药物评价研究

CSTPCD北大核心
影响因子:1.199
ISSN:1674-6376
年,卷(期):2024.47(5)